---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-011587"
form_type: "8-K"
ticker: "CPHI"
cik: "0001106644"
company_name: "CHINA PHARMA HOLDINGS, INC."
filed_at: "2024-02-08T23:59:59+00:00"
generated_at: "2026-06-06T05:18:33.101028+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# China Pharma subsidiary acquires psoriasis patent for $1.5M in stock

## Summary
- Helpson, a wholly owned subsidiary of China Pharma, entered a Technology Transfer Agreement with Lihua Li to acquire an invention patent for a psoriasis treatment.
- Total consideration is $1.5 million, paid via 15 million restricted shares of common stock at $0.10 per share to the transferor and two designees.
- If the product launches and generates profit within 10 years, Helpson will pay 10% of annual net profit in cash to the transferor.
- Shares will be issued in an offshore transaction exempt from registration under Regulation S of the Securities Act.

## SEC filing metadata
- accession: 0001213900-24-011587
- form_type: 8-K
- ticker: CPHI
- cik: 0001106644
- company_name: CHINA PHARMA HOLDINGS, INC.
- filed_at: 2024-02-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 3.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1106644/000121390024011587/0001213900-24-011587-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1106644/000121390024011587/ea193188-8k_chinapharma.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-011587
- JSON: https://secwatch.observer/filing/0001213900-24-011587.json
- Plain text: https://secwatch.observer/filing/0001213900-24-011587.txt

## Key facts
- Material Agreements
  CHINA PHARMA HOLDINGS, INC. entered into Technology Transfer Agreement with Lihua Li valued at $1.50 million (effective 2024-02-02).
  - Action: entry
  - Agreement: license
  - Counterparty: Lihua Li
  - Value: $1.50 million
  - Effective: 2024-02-02
  source text: ntered into a Technology Transfer Agreement (the “ Agreement ”) with Lihua Li (the “ Transferor ”). The Transferor owns an invention patent of a pharmaceutical composition for treatment of psoriasis (the “ Invention Patent ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1106644/000121390024011587/0001213900-24-011587-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.